Congress should strengthen the Medicaid safety net by reforming how the federal government funds state Medicaid programs, ...

We still don’t know whether integration delivers value. But it isn’t because integration has failed. It’s because we haven’t been asking (or measuring) the right question. As we approach new federal ...

Targeted transparency requirements, clearer guidance on contract pharmacy use, and stronger duplicate-discount safeguards ...

The American Medical Association now offers ethical guidance to physicians who are considering selling their private ...

E-bikes are not a transportation story that happens to involve health. They are a health story that happens to involve ...

Foreign reference pricing frameworks often differ from the way the US has historically valued medical innovation. A more ...

The question is not how clinicians can be made more resilient. It is why an institution performing at the highest level of ...

Perhaps the term “better” should not be defined by business metrics at all—but instead by the innovation’s health impacts ...

California cannot control whether mifepristone will remain available at the national level. But it can control whether ...

Exhibit 1 National health expenditures (NHE) and personal health care (PHC) expenditures, aggregate and per capita amounts, share of gross domestic product (GDP), and annual growth, selected calendar ...

The proposed changes are relatively modest, yet they represent an important procedural step forward in the implementation of ...

Congress should require the FDA to make DSCSA traceability data accessible and interpretable not only by regulatory agencies ...